A Phase 2 Open-Label Multicenter Multi-cohort Single-Arm Study to Investigate the Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children with Genotype 2 or 3 Chronic HCV Infection
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to see if giving SOF with RBV for 12 or 24 weeks to children with GT2 or GT# HCV is safe and can treat their HCV.
Description
The purpose of this study is to evaluate the efficacy and safety of treatment with SOF+RBV for adolescents and children with GT-2 and GT-3 chronic HCV infection.
Details
| Condition | hepatitis |
|---|---|
| Age | 3years - 17years |
| Clinical Study Identifier | TX4216 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.